Middlemen are negotiating contracts deals where pharmacists can't tell the patients that paying cash might actually be less expensive than the insurance co-payment. The middlemen then pocket the difference. Elsewhere on Capitol Hill, Republicans are signalling support for changes to the 340B drug discount program.

from Kaiser Health News http://ift.tt/2DwpNrv

Related Posts:

0 comments:

Post a Comment

Popular Posts